Status:
WITHDRAWN
Seizure Therapy With Intravenous Levetiracetam and Lorazepam
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
UCB Pharma
Conditions:
Seizures
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The overarching aim of STILL is assessment of IV LEV in the management of seizures in the ED setting. The main study endpoints are considered in the two patient groups of interest (SE and non-SE): * ...
Detailed Description
The study will enroll adults (age at least 18 years) in the EDs of MGH or BWH. Patients will be classified, depending upon their clinical presentation, into the SE group or the non-SE group. The total...
Eligibility Criteria
Inclusion
- seizure
Exclusion
- pregnancy
- renal failure
- hepatic impairment
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00465244
Start Date
January 1 2008
End Date
May 1 2010
Last Update
November 1 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.